Application Effect of Fast Track Surgery for Patients with Lung Cancer: 
A Meta-analysis

• Published in: Zhongguo fei ai za zhi Vol. 19; no. 12; pp. 827 - 836
• Main Authors: Xia, Yan, Chang, Shuwen, Ye, Jingting, Xue, Jin, Shu, Yusheng
• Format: Journal Article
• Language: Chinese
• Published: China Chinese Anti-Cancer Association Chinese Antituberculosis Association 20.12.2016; Chinese Anti-Cancer Association; Chinese Antituberculosis Association
• Subjects: Cancer surgery; China; Controlled Clinical Trials as Topic; Fast track surgery; Humans; Length of Stay; Lobectomy; Lung cancer; Lung neoplasms; Lung Neoplasms - economics; Lung Neoplasms - physiopathology; Lung Neoplasms - surgery; Meta-analysis; Nosocomial infections; Ostomy; Postoperative Complications - economics; Postoperative Complications - prevention & control; Pulmonary Surgical Procedures - economics; Pulmonary Surgical Procedures - methods; Randomized Controlled Trials as Topic; Recovery of Function; Rehabilitation; Systematic review; Time Factors; Video-assisted thoracoscopic surgery; Beijing China; China
• ISSN: 1009-3419; 1999-6187
• DOI: 10.3779/j.issn.1009-3419.2016.12.05

Fast track surgery (FTS) can accelerate rehabilitation and reduce postoperative hospital stay. It has been effectively applied to several surgical diseases. However, the safety and effectiveness of FTS for patients with lung cancer in China is unclear. This meta-analysis aimed to evaluate the effect of FTS undergoing lung cancer surgery in China. Using home and abroad databases to search all documents required. The deadline of retrieval was January 31, 2016. Then the studies were screened according to the inclusion and exclusion criteria. Data were analyzed by RevMan 5.3 software. 8 randomized controlled trials (RCTs) and 5 clinical controlled trials (CCTs) with 1,241 patients were eligible for analysis. Compared with control group, FTS group can significantly shorten postoperative hospital time (MD=-3.61, 95%CI: -5.05--2.16, P<0.000,01) and chest tube duration (MD=-2.62, 95%CI: -3.07-2.17, P<0.000,01), reduce incidence of postoperative complications (OR=0.30, 95%CI: 0.19-0.47, P<0.000,01) and hospitalization